{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:30:33Z","timestamp":1792189833616,"version":"4.4.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute tumor lysis syndrome (ATLS) is caused by the rapid breakdown of tumor cells, leading to electrolyte imbalances and renal dysfunction. The risk of ATLS is particularly high in lymphoma, and therefore it is crucial to consider this risk when initiating chemotherapy. However, risk factors associated with ATLS in dogs remain largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Identify potential risk factors for ATLS in dogs with multicentric lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 24 dogs diagnosed with B-cell high-grade multicentric lymphoma that received chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood samples were collected before treatment and on days 3, 5, and 8 after treatment. Serum concentrations of uric acid, potassium, phosphorus, calcium, and creatinine were measured based on the Cairo-Bishop Criteria to classify cases as laboratory tumor lysis syndrome (LTLS) or clinical tumor lysis syndrome (CTLS). Clinical variables, including signalment, clinical signs, comorbidities, stage, chemotherapy agents, hematologic and biochemical findings, chemotherapy response, and clinical outcomes were compared between two groups: normal and LTLS\/CTLS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 24 dogs, LTLS occurred in 5 (20.8%), whereas CTLS occurred in 2 (8.3%). The development of LTLS\/CTLS was strongly associated with the initial administration of L-asparaginase, presence of chronic kidney disease (CKD), weight loss, and metabolic acidosis. However, no significant differences were observed between the normal and LTLS\/CTLS groups regarding signalment, clinical signs, stage, CBC abnormality, and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Evaluating the four risk factors at the initiation of chemotherapy may help establish personalized prevention strategies for ATLS in dogs with multicentric lymphoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jvimsj\/aalaf088","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:13:26Z","timestamp":1770034406000},"source":"Crossref","is-referenced-by-count":1,"title":["A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy"],"prefix":"10.1093","volume":"40","author":[{"given":"Hiroki","family":"Yamazaki","sequence":"first","affiliation":[{"name":"Companion Animal Internal Medicine, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University , Ebetsu, Hokkaido, 069-8501 ,","place":["Japan"]},{"name":"The Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Metropolitan University, 1-58 Rinku-Oraikita, Izumisano 598-8531 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konami","family":"Nagai","sequence":"additional","affiliation":[{"name":"Companion Animal Internal Medicine, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University , Ebetsu, Hokkaido, 069-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Oncology, Osaka Hospital, Japan Animal Referral Medical Center, 3-14-7 Senbanishi, Minoo-shi, Osaka 562-0036 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Noguchi","sequence":"additional","affiliation":[{"name":"The Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Metropolitan University, 1-58 Rinku-Oraikita, Izumisano 598-8531 ,","place":["Japan"]},{"name":"Department of Oncology, Osaka Hospital, Japan Animal Referral Medical Center, 3-14-7 Senbanishi, Minoo-shi, Osaka 562-0036 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Companion Animal Veterinary Surgery, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582-1 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Sakai","sequence":"additional","affiliation":[{"name":"Companion Animal Veterinary Surgery, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582-1 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidow","family":"Torisu","sequence":"additional","affiliation":[{"name":"Companion Animal Veterinary Surgery, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582-1 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026020706115877800_ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"key":"2026020706115877800_ref2","first-page":"356","article-title":"The nucleic acids and other phosphorus compounds of human leukemic leukocytes: relation to cell maturity","volume":"48","author":"Duerst","year":"1956","journal-title":"J Lab Clin Med"},{"key":"2026020706115877800_ref3","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026020706115877800_ref4","first-page":"322","article-title":"Metabolic emergencies in the cancer patient","volume":"27","author":"Flombaum","year":"2000","journal-title":"Semin Oncol"},{"key":"2026020706115877800_ref5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","article-title":"Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus","volume":"149","author":"Cairo","year":"2010","journal-title":"Br J Haematol"},{"key":"2026020706115877800_ref6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1292\/jvms.14-0503","article-title":"Central venous blood gas and acid-base status in conscious dogs and cats","volume":"77","author":"Tamura","year":"2015","journal-title":"J Vet Med Sci"},{"key":"2026020706115877800_ref7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/vco.12032","article-title":"Response evaluation criteria for solid tumors in dogs (v1.0): a veterinary cooperative oncology group consensus document. Vet comp","volume":"13","author":"Nguyen","year":"2015","journal-title":"Oncol."},{"key":"2026020706115877800_ref8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/vco.12677","article-title":"Veterinary cooperative oncology group-common terminology criteria for adverse events (VCOG-CTCAE v2) following investigational therapy in dogs and cats","volume":"19","author":"LeBlanc","year":"2021","journal-title":"Vet Comp Oncol"},{"key":"2026020706115877800_ref9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bjh.13403","article-title":"Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in haematology","volume":"169","author":"Jones","year":"2015","journal-title":"Br J Haematol"},{"key":"2026020706115877800_ref10","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/j.1939-1676.2007.tb01965.x","article-title":"Successful treatment of acute tumor lysis syndrome in a dog with multicentric lymphoma","volume":"21","author":"Vickery","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020706115877800_ref11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0093-7754(01)90254-4","article-title":"Acute tumor lysis syndrome","volume":"28","author":"Altman","year":"2001","journal-title":"Semin Oncol"},{"key":"2026020706115877800_ref12","volume-title":"Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat","author":"Ettinger","year":"2000","edition":"5th"},{"key":"2026020706115877800_ref13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2460\/ajvr.1986.47.04.910","article-title":"Uric acid and phosphorus excretion in dogs with lymphosarcoma","volume":"47","author":"Page","year":"1986","journal-title":"Am J Vet Res"},{"key":"2026020706115877800_ref14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0195-5616(90)50083-2","article-title":"Management of complications of cancer chemotherapy","volume":"20","author":"Couto","year":"1990","journal-title":"Vet Clin N Am Small Anim Pract"},{"key":"2026020706115877800_ref15","first-page":"86","volume-title":"BSAVA Manual of Canine and Feline Oncology","author":"Lana","year":"2003","edition":"2nd ed."},{"key":"2026020706115877800_ref16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1751-0813.2007.00127.x","article-title":"Acute tumour lysis syndrome in a dog with B-cell multicentric lymphoma","volume":"85","author":"Mylonakis","year":"2007","journal-title":"Aust Vet J"},{"key":"2026020706115877800_ref17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/1097-0142(19900715)66:2&lt;246::AID-CNCR2820660209&gt;3.0.CO;2-B","article-title":"Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide","volume":"66","author":"McCroskey","year":"1990","journal-title":"Cancer."}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf088\/66706096\/aalaf088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf088\/66706096\/aalaf088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:12:06Z","timestamp":1770462726000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1093\/jvimsj\/aalaf088\/8454579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jvimsj\/aalaf088","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"aalaf088"}}